Prolonged inflammatory pain modifies corticotropin-releasing factor-induced opioid peptide release in the hypothalamus
- PMID: 1686211
- DOI: 10.1016/0006-8993(91)91535-9
Prolonged inflammatory pain modifies corticotropin-releasing factor-induced opioid peptide release in the hypothalamus
Abstract
The influence of prolonged pain upon hypothalamic opioid peptide release in vitro was examined in rats subjected to Freund's adjuvant (FA)-induced unilateral inflammation of the hindlimb. Basal release of enkephalin (ENK) but not beta-endorphin (END) or dynorphin (DYN) was increased 10 days following FA treatment. Superfusion of corticotropin-releasing factor (CRF; 10(-8) M) stimulated the release of opioid peptides in control hypothalami. CRF, however, failed to modify beta-END and DYN release in hypothalami of FA-treated rats, whereas ENK release was markedly reduced. In contrast, KCl-stimulated opioid peptide release did not differ between FA and control hypothalami. These data demonstrate that prolonged inflammatory pain alters the responsiveness of hypothalamic opioid systems to CRF. It is suggested that this effect is mediated at the level of the CRF neuron or its receptor.
Similar articles
-
Stimulation of hypothalamic beta-endorphin and dynorphin release by corticotropin-releasing factor (in vitro).Brain Res. 1986 Dec 3;399(1):152-5. doi: 10.1016/0006-8993(86)90610-4. Brain Res. 1986. PMID: 2879612
-
Concomitant changes in the in vitro and in vivo release of opioid peptides and luteinizing hormone-releasing hormone from the hypothalamus following blockade of receptors for corticotropin-releasing factor.Neuroendocrinology. 1988 Jun;47(6):545-50. doi: 10.1159/000124967. Neuroendocrinology. 1988. PMID: 2840600
-
Significance of testosterone in regulating hypothalamic content and in vitro release of beta-endorphin and dynorphin.J Neurochem. 1987 Sep;49(3):742-7. doi: 10.1111/j.1471-4159.1987.tb00956.x. J Neurochem. 1987. PMID: 2886553
-
The regulation of hypothalamic corticotropin-releasing factor release: in vitro studies.Ciba Found Symp. 1993;172:129-43; discussion 143-50. doi: 10.1002/9780470514368.ch7. Ciba Found Symp. 1993. PMID: 8491084 Review.
-
The role of corticotropin-releasing factor in pain and analgesia.Pain. 2000 Jan;84(1):1-12. doi: 10.1016/S0304-3959(99)00193-1. Pain. 2000. PMID: 10601667 Review.
Cited by
-
Superior control of inflammatory pain by corticotropin-releasing factor receptor 1 via opioid peptides in distinct pain-relevant brain areas.J Neuroinflammation. 2022 Jun 15;19(1):148. doi: 10.1186/s12974-022-02498-8. J Neuroinflammation. 2022. PMID: 35705992 Free PMC article.
-
The long-term impact of early life pain on adult responses to anxiety and stress: Historical perspectives and empirical evidence.Exp Neurol. 2016 Jan;275 Pt 2(Pt 2):261-73. doi: 10.1016/j.expneurol.2015.07.017. Epub 2015 Jul 22. Exp Neurol. 2016. PMID: 26210872 Free PMC article. Review.
-
Corticotropin-releasing factor mediates bone cancer induced pain through neuronal activation in rat spinal cord.Tumour Biol. 2015 Dec;36(12):9559-65. doi: 10.1007/s13277-015-3670-1. Epub 2015 Jul 3. Tumour Biol. 2015. PMID: 26138585
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical